These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7720042)

  • 21. Cyclin D1, EMS1 and 11q13 amplification in breast cancer.
    Ormandy CJ; Musgrove EA; Hui R; Daly RJ; Sutherland RL
    Breast Cancer Res Treat; 2003 Apr; 78(3):323-35. PubMed ID: 12755491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome 11q13 abnormalities in human breast cancer.
    Fantl V; Smith R; Brookes S; Dickson C; Peters G
    Cancer Surv; 1993; 18():77-94. PubMed ID: 8013002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
    Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression.
    Barbareschi M; Pelosio P; Caffo O; Buttitta F; Pellegrini S; Barbazza R; Dalla Palma P; Bevilacqua G; Marchetti A
    Int J Cancer; 1997 Apr; 74(2):171-4. PubMed ID: 9133450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
    Bartkova J; Lukas J; Müller H; Strauss M; Gusterson B; Bartek J
    Cancer Res; 1995 Feb; 55(4):949-56. PubMed ID: 7850812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
    Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
    Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
    Wang TC; Cardiff RD; Zukerberg L; Lees E; Arnold A; Schmidt EV
    Nature; 1994 Jun; 369(6482):669-71. PubMed ID: 8208295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin D1/PRAD1 as a central target in oncogenesis.
    Hosokawa Y; Arnold A
    J Lab Clin Med; 1996 Mar; 127(3):246-52. PubMed ID: 9273357
    [No Abstract]   [Full Text] [Related]  

  • 30. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
    Yuan B; Oechsli MN; Hendler FJ
    Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification of 11q13 DNA sequences in human breast cancer: D11S97 identifies a region tightly linked to BCL1 which can be amplified separately.
    Szepetowski P; Courseaux A; Carle GF; Theillet C; Gaudray P
    Oncogene; 1992 Apr; 7(4):751-5. PubMed ID: 1565470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
    Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O
    Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
    Dedes KJ; Lopez-Garcia MA; Geyer FC; Lambros MB; Savage K; Vatcheva R; Wilkerson P; Wetterskog D; Lacroix-Triki M; Natrajan R; Reis-Filho JS
    Breast Cancer Res Treat; 2010 Dec; 124(3):653-66. PubMed ID: 20213079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
    Holm K; Staaf J; Jönsson G; Vallon-Christersson J; Gunnarsson H; Arason A; Magnusson L; Barkardottir RB; Hegardt C; Ringnér M; Borg A
    Breast Cancer Res Treat; 2012 Jun; 133(2):583-94. PubMed ID: 22002566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
    Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
    Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA amplification at 11q13.5-q14 in human breast cancer.
    Szepetowski P; Ollendorff V; Grosgeorge J; Courseaux A; Birnbaum D; Theillet C; Gaudray P
    Oncogene; 1992 Dec; 7(12):2513-7. PubMed ID: 1461654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer.
    Fantl V; Richards MA; Smith R; Lammie GA; Johnstone G; Allen D; Gregory W; Peters G; Dickson C; Barnes DM
    Eur J Cancer; 1990 Apr; 26(4):423-9. PubMed ID: 2141507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
    Rodriguez C; Hughes-Davies L; Vallès H; Orsetti B; Cuny M; Ursule L; Kouzarides T; Theillet C
    Clin Cancer Res; 2004 Sep; 10(17):5785-91. PubMed ID: 15355907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.